Opana ER-induced thrombotic microangiopathy

摘要

In this issue of Blood, Hunt et al elucidate the pathogenesis of a specific form of thrombotic microangiopathy (TMA) induced by the IV abuse of extended-release oxymorphone hydrochloride (Opana ER) tablets.